| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 36 | 2025 | 648 | 6.190 |
Why?
|
| Peripheral Arterial Disease | 23 | 2024 | 172 | 6.090 |
Why?
|
| Lower Extremity | 19 | 2024 | 164 | 5.390 |
Why?
|
| Aortic Aneurysm, Abdominal | 17 | 2025 | 249 | 4.530 |
Why?
|
| Blood Vessel Prosthesis Implantation | 26 | 2025 | 310 | 4.240 |
Why?
|
| Vascular Surgical Procedures | 18 | 2025 | 261 | 4.120 |
Why?
|
| Endarterectomy, Carotid | 8 | 2024 | 91 | 2.820 |
Why?
|
| Ischemia | 13 | 2024 | 204 | 2.420 |
Why?
|
| Carotid Stenosis | 8 | 2025 | 105 | 2.370 |
Why?
|
| Treatment Outcome | 67 | 2025 | 5647 | 2.290 |
Why?
|
| Risk Factors | 63 | 2025 | 5338 | 2.170 |
Why?
|
| Limb Salvage | 11 | 2024 | 69 | 2.030 |
Why?
|
| Time Factors | 50 | 2025 | 3757 | 2.020 |
Why?
|
| Retrospective Studies | 71 | 2025 | 6627 | 1.960 |
Why?
|
| Intermittent Claudication | 6 | 2020 | 56 | 1.840 |
Why?
|
| Vascular Patency | 15 | 2024 | 139 | 1.770 |
Why?
|
| Databases, Factual | 31 | 2025 | 866 | 1.630 |
Why?
|
| Quality Indicators, Health Care | 2 | 2025 | 337 | 1.470 |
Why?
|
| Hospital Mortality | 13 | 2025 | 874 | 1.460 |
Why?
|
| Risk Assessment | 33 | 2025 | 2071 | 1.440 |
Why?
|
| Arteriovenous Shunt, Surgical | 9 | 2020 | 44 | 1.380 |
Why?
|
| Stents | 9 | 2025 | 491 | 1.360 |
Why?
|
| Femoral Artery | 8 | 2025 | 110 | 1.320 |
Why?
|
| Aged | 58 | 2025 | 14384 | 1.270 |
Why?
|
| Saphenous Vein | 5 | 2020 | 52 | 1.220 |
Why?
|
| Upper Extremity | 7 | 2022 | 54 | 1.210 |
Why?
|
| Vascular System Injuries | 4 | 2021 | 21 | 1.170 |
Why?
|
| Postoperative Complications | 22 | 2025 | 1304 | 1.150 |
Why?
|
| Hospitals, High-Volume | 2 | 2025 | 35 | 1.150 |
Why?
|
| Elective Surgical Procedures | 8 | 2025 | 123 | 1.140 |
Why?
|
| Blood Vessel Prosthesis | 10 | 2025 | 224 | 1.140 |
Why?
|
| Carotid Artery Diseases | 5 | 2022 | 66 | 1.090 |
Why?
|
| Male | 67 | 2025 | 29799 | 1.040 |
Why?
|
| Vascular Diseases | 3 | 2020 | 81 | 1.040 |
Why?
|
| Aged, 80 and over | 31 | 2025 | 5443 | 1.030 |
Why?
|
| Ticlopidine | 2 | 2017 | 49 | 1.010 |
Why?
|
| Patient Selection | 9 | 2020 | 488 | 1.010 |
Why?
|
| Humans | 87 | 2025 | 63283 | 1.000 |
Why?
|
| Kidney Failure, Chronic | 5 | 2020 | 207 | 0.960 |
Why?
|
| Insulins | 2 | 2023 | 15 | 0.950 |
Why?
|
| Hospitals, Low-Volume | 1 | 2025 | 21 | 0.950 |
Why?
|
| Renal Dialysis | 9 | 2020 | 198 | 0.940 |
Why?
|
| Female | 65 | 2025 | 32776 | 0.940 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 226 | 0.890 |
Why?
|
| Practice Guidelines as Topic | 3 | 2025 | 736 | 0.880 |
Why?
|
| Computed Tomography Angiography | 3 | 2024 | 123 | 0.880 |
Why?
|
| Wounds, Penetrating | 2 | 2021 | 26 | 0.880 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2025 | 111 | 0.870 |
Why?
|
| United States | 28 | 2025 | 7828 | 0.870 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2024 | 46 | 0.840 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2021 | 50 | 0.840 |
Why?
|
| Reoperation | 12 | 2025 | 291 | 0.830 |
Why?
|
| Drug-Eluting Stents | 1 | 2024 | 62 | 0.820 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 33 | 0.810 |
Why?
|
| Cardiovascular Agents | 1 | 2024 | 104 | 0.800 |
Why?
|
| Aneurysm | 2 | 2022 | 60 | 0.790 |
Why?
|
| Middle Aged | 47 | 2025 | 17535 | 0.790 |
Why?
|
| Multivariate Analysis | 16 | 2021 | 935 | 0.780 |
Why?
|
| Comorbidity | 14 | 2024 | 1118 | 0.760 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 537 | 0.740 |
Why?
|
| Patient Care Team | 1 | 2024 | 337 | 0.740 |
Why?
|
| Stroke | 7 | 2025 | 1191 | 0.720 |
Why?
|
| Iliac Vein | 1 | 2021 | 9 | 0.720 |
Why?
|
| Abdominal Injuries | 1 | 2021 | 30 | 0.700 |
Why?
|
| Radiography, Interventional | 2 | 2018 | 74 | 0.700 |
Why?
|
| Financial Support | 1 | 2020 | 5 | 0.680 |
Why?
|
| Gift Giving | 1 | 2020 | 8 | 0.670 |
Why?
|
| Health Care Sector | 1 | 2020 | 20 | 0.670 |
Why?
|
| Surgeons | 2 | 2020 | 187 | 0.670 |
Why?
|
| Vascular Grafting | 5 | 2019 | 39 | 0.670 |
Why?
|
| Chi-Square Distribution | 14 | 2018 | 417 | 0.660 |
Why?
|
| Catheterization, Peripheral | 4 | 2025 | 53 | 0.660 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2019 | 1 | 0.650 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 149 | 0.640 |
Why?
|
| Angioplasty, Balloon | 2 | 2024 | 58 | 0.630 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 288 | 0.630 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 95 | 0.600 |
Why?
|
| Multimodal Imaging | 2 | 2018 | 67 | 0.600 |
Why?
|
| Pneumonectomy | 1 | 2019 | 109 | 0.590 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 1084 | 0.590 |
Why?
|
| Patient Compliance | 1 | 2021 | 360 | 0.590 |
Why?
|
| Prosthesis-Related Infections | 2 | 2018 | 34 | 0.570 |
Why?
|
| Femoral Vein | 3 | 2019 | 19 | 0.570 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 58 | 0.560 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 71 | 0.560 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 65 | 0.560 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2018 | 70 | 0.550 |
Why?
|
| Blood Transfusion | 2 | 2017 | 161 | 0.520 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 40 | 0.520 |
Why?
|
| Odds Ratio | 12 | 2020 | 768 | 0.510 |
Why?
|
| Asymptomatic Diseases | 6 | 2020 | 49 | 0.510 |
Why?
|
| Prosthesis Design | 7 | 2025 | 227 | 0.510 |
Why?
|
| Angioplasty | 2 | 2022 | 51 | 0.470 |
Why?
|
| Kaplan-Meier Estimate | 7 | 2019 | 422 | 0.470 |
Why?
|
| Aspirin | 1 | 2016 | 171 | 0.450 |
Why?
|
| Wounds, Gunshot | 3 | 2020 | 56 | 0.450 |
Why?
|
| Hemorrhage | 1 | 2016 | 267 | 0.440 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 115 | 0.430 |
Why?
|
| Medicare | 4 | 2023 | 610 | 0.420 |
Why?
|
| Patient Readmission | 6 | 2019 | 430 | 0.410 |
Why?
|
| Logistic Models | 11 | 2018 | 1275 | 0.400 |
Why?
|
| Aortic Aneurysm | 1 | 2014 | 87 | 0.400 |
Why?
|
| Smoking | 1 | 2018 | 865 | 0.400 |
Why?
|
| Propensity Score | 6 | 2019 | 156 | 0.390 |
Why?
|
| Vascular Access Devices | 2 | 2024 | 15 | 0.370 |
Why?
|
| Critical Illness | 7 | 2018 | 322 | 0.370 |
Why?
|
| Coronary Stenosis | 1 | 2012 | 39 | 0.370 |
Why?
|
| Connective Tissue | 1 | 2011 | 12 | 0.370 |
Why?
|
| Cysts | 1 | 2011 | 41 | 0.360 |
Why?
|
| Graft Occlusion, Vascular | 6 | 2021 | 62 | 0.360 |
Why?
|
| Device Removal | 3 | 2018 | 67 | 0.360 |
Why?
|
| Recurrence | 5 | 2020 | 643 | 0.350 |
Why?
|
| Aortic Rupture | 3 | 2021 | 54 | 0.340 |
Why?
|
| Length of Stay | 7 | 2020 | 811 | 0.340 |
Why?
|
| Registries | 9 | 2021 | 884 | 0.330 |
Why?
|
| Coronary Artery Bypass | 1 | 2012 | 297 | 0.330 |
Why?
|
| Wound Healing | 3 | 2016 | 189 | 0.310 |
Why?
|
| Age Factors | 6 | 2020 | 1560 | 0.310 |
Why?
|
| Endoleak | 4 | 2023 | 42 | 0.300 |
Why?
|
| Hematoma | 2 | 2019 | 80 | 0.290 |
Why?
|
| Severity of Illness Index | 10 | 2020 | 1543 | 0.290 |
Why?
|
| Firearms | 2 | 2019 | 69 | 0.280 |
Why?
|
| Disease-Free Survival | 4 | 2018 | 242 | 0.270 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 715 | 0.260 |
Why?
|
| Clinical Decision-Making | 4 | 2020 | 165 | 0.250 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 298 | 0.250 |
Why?
|
| New England | 3 | 2019 | 273 | 0.230 |
Why?
|
| Benchmarking | 1 | 2025 | 138 | 0.220 |
Why?
|
| Vena Cava Filters | 2 | 2014 | 23 | 0.220 |
Why?
|
| Interdisciplinary Communication | 1 | 2024 | 105 | 0.210 |
Why?
|
| Diffusion of Innovation | 1 | 2024 | 58 | 0.210 |
Why?
|
| Vascular Calcification | 1 | 2024 | 25 | 0.210 |
Why?
|
| Survival Rate | 2 | 2018 | 850 | 0.210 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2024 | 134 | 0.210 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 2460 | 0.210 |
Why?
|
| Carotid Artery, Internal | 2 | 2022 | 68 | 0.210 |
Why?
|
| Paclitaxel | 1 | 2024 | 99 | 0.210 |
Why?
|
| Operative Time | 3 | 2020 | 92 | 0.210 |
Why?
|
| Spinal Cord Ischemia | 1 | 2023 | 16 | 0.210 |
Why?
|
| History, 21st Century | 1 | 2024 | 171 | 0.200 |
Why?
|
| Health Services Needs and Demand | 1 | 2024 | 209 | 0.200 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 912 | 0.200 |
Why?
|
| Aortography | 2 | 2022 | 59 | 0.200 |
Why?
|
| Prevalence | 2 | 2024 | 1377 | 0.190 |
Why?
|
| Fluoroscopy | 2 | 2018 | 65 | 0.180 |
Why?
|
| Popliteal Artery | 2 | 2019 | 27 | 0.180 |
Why?
|
| Ligation | 1 | 2021 | 39 | 0.180 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 115 | 0.180 |
Why?
|
| Adult | 10 | 2024 | 16771 | 0.180 |
Why?
|
| Patient Acuity | 1 | 2021 | 20 | 0.180 |
Why?
|
| Watchful Waiting | 1 | 2021 | 29 | 0.170 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 1093 | 0.170 |
Why?
|
| Heart Diseases | 2 | 2020 | 217 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 108 | 0.170 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2020 | 9 | 0.170 |
Why?
|
| Conflict of Interest | 1 | 2020 | 37 | 0.160 |
Why?
|
| Disclosure | 1 | 2020 | 55 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 111 | 0.160 |
Why?
|
| Serum Albumin, Human | 1 | 2019 | 7 | 0.160 |
Why?
|
| Hypoalbuminemia | 1 | 2019 | 7 | 0.160 |
Why?
|
| Axillary Artery | 1 | 2019 | 8 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1649 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2020 | 753 | 0.160 |
Why?
|
| Constriction, Pathologic | 2 | 2024 | 129 | 0.160 |
Why?
|
| Forearm | 1 | 2019 | 21 | 0.160 |
Why?
|
| Aorta, Abdominal | 1 | 2019 | 59 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2020 | 163 | 0.150 |
Why?
|
| Wrist | 1 | 2019 | 39 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 214 | 0.150 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 730 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 180 | 0.150 |
Why?
|
| Reference Values | 1 | 2019 | 335 | 0.150 |
Why?
|
| Personnel Selection | 1 | 2019 | 55 | 0.150 |
Why?
|
| Radiation Exposure | 1 | 2018 | 22 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2023 | 3280 | 0.150 |
Why?
|
| General Surgery | 1 | 2021 | 210 | 0.150 |
Why?
|
| Exercise Test | 1 | 2020 | 252 | 0.150 |
Why?
|
| Patient-Specific Modeling | 1 | 2018 | 11 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2018 | 74 | 0.150 |
Why?
|
| Anesthesia, Local | 1 | 2018 | 20 | 0.140 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 98 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2022 | 366 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2018 | 46 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 37 | 0.140 |
Why?
|
| Thrombectomy | 1 | 2020 | 229 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 217 | 0.140 |
Why?
|
| Models, Cardiovascular | 1 | 2018 | 79 | 0.140 |
Why?
|
| New York City | 2 | 2014 | 80 | 0.140 |
Why?
|
| Heparin | 1 | 2018 | 116 | 0.140 |
Why?
|
| Faculty, Medical | 1 | 2019 | 198 | 0.130 |
Why?
|
| Perioperative Period | 1 | 2017 | 21 | 0.130 |
Why?
|
| Physicians | 1 | 2022 | 471 | 0.130 |
Why?
|
| Transfusion Reaction | 1 | 2017 | 46 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 175 | 0.130 |
Why?
|
| Young Adult | 3 | 2021 | 4683 | 0.130 |
Why?
|
| Protective Factors | 1 | 2016 | 33 | 0.130 |
Why?
|
| Anemia | 1 | 2017 | 127 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 1613 | 0.120 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2015 | 5 | 0.120 |
Why?
|
| Ribs | 1 | 2015 | 4 | 0.120 |
Why?
|
| Subclavian Vein | 1 | 2015 | 12 | 0.120 |
Why?
|
| Sex Factors | 2 | 2020 | 979 | 0.120 |
Why?
|
| Health Status | 4 | 2019 | 435 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2020 | 1988 | 0.120 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 48 | 0.110 |
Why?
|
| Patient Preference | 1 | 2015 | 84 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 463 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 196 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2018 | 495 | 0.110 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 72 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2014 | 147 | 0.110 |
Why?
|
| Endarterectomy | 1 | 2013 | 18 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2019 | 550 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2014 | 201 | 0.110 |
Why?
|
| ROC Curve | 1 | 2014 | 281 | 0.100 |
Why?
|
| Skin Transplantation | 1 | 2014 | 156 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2021 | 801 | 0.100 |
Why?
|
| Angiography | 1 | 2013 | 152 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 137 | 0.100 |
Why?
|
| HIV Infections | 1 | 2020 | 967 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2014 | 119 | 0.100 |
Why?
|
| Veins | 2 | 2023 | 64 | 0.090 |
Why?
|
| Edema | 1 | 2011 | 43 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2012 | 220 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 98 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 185 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2012 | 306 | 0.080 |
Why?
|
| Quality of Life | 1 | 2016 | 1223 | 0.080 |
Why?
|
| Injury Severity Score | 2 | 2020 | 109 | 0.080 |
Why?
|
| Patient Discharge | 3 | 2018 | 511 | 0.070 |
Why?
|
| North America | 2 | 2019 | 111 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 784 | 0.070 |
Why?
|
| Boston | 2 | 2018 | 252 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 694 | 0.070 |
Why?
|
| Heart Failure | 1 | 2014 | 913 | 0.060 |
Why?
|
| Incidence | 2 | 2020 | 1375 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1168 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 1355 | 0.060 |
Why?
|
| Infant | 2 | 2020 | 1649 | 0.060 |
Why?
|
| Biomarkers | 2 | 2019 | 1396 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 81 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2022 | 42 | 0.050 |
Why?
|
| Paraparesis | 1 | 2021 | 9 | 0.040 |
Why?
|
| Retreatment | 1 | 2021 | 47 | 0.040 |
Why?
|
| Workload | 1 | 2021 | 125 | 0.040 |
Why?
|
| Embolectomy | 1 | 2020 | 15 | 0.040 |
Why?
|
| Dependent Ambulation | 1 | 2019 | 2 | 0.040 |
Why?
|
| Child | 2 | 2020 | 4522 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2019 | 49 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 2020 | 84 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2020 | 114 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 2019 | 18 | 0.040 |
Why?
|
| Arteries | 1 | 2020 | 81 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 96 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 393 | 0.040 |
Why?
|
| Consent Forms | 1 | 2019 | 15 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 72 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2019 | 31 | 0.040 |
Why?
|
| Authorship | 1 | 2019 | 23 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 127 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 74 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2020 | 192 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 190 | 0.040 |
Why?
|
| Career Mobility | 1 | 2019 | 64 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 6238 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2018 | 38 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2019 | 83 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 350 | 0.040 |
Why?
|
| Safety-net Providers | 1 | 2018 | 30 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 349 | 0.040 |
Why?
|
| After-Hours Care | 1 | 2017 | 7 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 64 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2018 | 132 | 0.030 |
Why?
|
| Hematocrit | 1 | 2017 | 34 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 777 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 135 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 725 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2017 | 202 | 0.030 |
Why?
|
| Medicaid | 1 | 2020 | 362 | 0.030 |
Why?
|
| Kidney | 1 | 2018 | 447 | 0.030 |
Why?
|
| Phlebography | 1 | 2015 | 44 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 407 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2015 | 69 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 91 | 0.030 |
Why?
|